FIG. 1 is a front view of a first image in a sequence of a display screen or portion thereof with graphical user interface for modifying a report with an abstraction tool showing our new design;
FIG. 2 is a front view of a second image thereof;
FIG. 3 is a front view of a third image thereof;
FIG. 4 is a front view of a fourth image thereof;
FIG. 5 is a front view of a fifth image thereof;
FIG. 6 is a front view of a sixth image thereof;
FIG. 7 is a front view of a seventh image thereof;
FIG. 8 is a front view of an eighth image thereof;
FIG. 9 is a front view of a ninth image thereof;
FIG. 10 is a front view of a tenth image thereof;
FIG. 11 is a front view of an eleventh image thereof;
FIG. 12 is a front view of a twelfth image thereof;
FIG. 13 is a front view of a thirteenth image thereof;
FIG. 14 is a front view of a fourteenth image thereof; and,
FIG. 15 is a front view of a fifteenth image thereof.
The outermost broken lined rectangles indicate a boundary of a display screen or a portion thereof and form no part of the claimed design. The broken lined text and characters form no part of the claimed design.
The appearance of the animated images sequentially transition from FIG. 1 to FIG. 15. The process or period in which one image transitions to another forms no part of the claimed design.
Barnard, Cindy K., Byrapuneni, Sambasivarao, Chapagain, Diwakar, Dorge, Archana P., Jeu, Catherine M., Kesavan, Rengaraja, Parekh, Kaushal D., Ramanathan, Raman, Schlossman, David M., Sharma, Vishakha
Patent |
Priority |
Assignee |
Title |
ER1217, |
|
|
|
ER1559, |
|
|
|
ER1977, |
|
|
|
ER27, |
|
|
|
ER3002, |
|
|
|
ER3984, |
|
|
|
ER4227, |
|
|
|
ER5542, |
|
|
|
ER6248, |
|
|
|
ER792, |
|
|
|
ER9077, |
|
|
|
ER9616, |
|
|
|
Patent |
Priority |
Assignee |
Title |
20160349949, |
|
|
|
20190391825, |
|
|
|
D733176, |
Aug 14 2013 |
BETTER CHINESE, LLC.; BETTER CHINESE, LLC , |
Display screen or portion thereof with transitional image sequence |
D809530, |
Dec 20 2016 |
SMARTORG, INC.; SMARTORG, INC |
Display screen or portion thereof with an animated graphical user interface |
D836652, |
Oct 04 2016 |
Honeywell International Inc.; Honeywell International Inc |
Display screen or portion thereof with animated graphical user interface |
D841031, |
Sep 21 2016 |
EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC |
Display screen with animated graphical user interface |
D860238, |
Mar 28 2018 |
INNOPLEXUS AG |
Display screen with transitional graphical user interface |
D868104, |
May 24 2018 |
ADP, INC |
Display screen or portion thereof with an animated graphical user interface |
D871443, |
May 24 2018 |
ADP, INC |
Display screen or portion thereof with an animated graphical user interface |
D874481, |
Jun 29 2018 |
INNOPLEXUS AG |
Display screen with transitional graphical user interface |
D881211, |
Dec 22 2015 |
JPMORGAN CHASE BANK, N A |
Display screen or portion thereof with a graphical user interface |
D888739, |
May 24 2018 |
ADP, INC |
Display screen or a portion thereof with a graphical user interface |
D890199, |
Sep 28 2018 |
INNOPLEXUS AG |
Display screen with transitional graphical user interface |
D892849, |
Sep 27 2018 |
INNOPLEXUS AG; INNOPLEXUS CONSULTING SERVICES PVT LTD |
Display screen with transitional graphical user interface |
D902226, |
Sep 12 2016 |
Roche Molecular Systems, Inc |
Display screen or portion thereof with graphical user interface for timeline information for multidisciplinary cancer treatment planning |
D905734, |
May 24 2018 |
ADP, INC |
Display screen or a portion thereof with an animated graphical user interface |
D906360, |
Sep 18 2016 |
|
Display screen or portion thereof with an animated graphical user interface |
D922420, |
Nov 15 2019 |
NETWOLVES NETWORK SERVICES, LLC |
Display screen with graphical user interface for network monitoring dashboard |
D930022, |
Oct 14 2019 |
ASTEK POLSKA SP ZO O ; ROCHE POLSKA SP ZO O; Roche Molecular Systems, Inc; F HOFFMANN-LA ROCHE AG |
Display screen or portion thereof with graphical user interface for interactive guidelines for multidisciplinary cancer treatment planning |
D931314, |
Oct 14 2019 |
ASTEK POLSKA SP ZO O ; ROCHE POLSKA SP ZO O; Roche Molecular Systems, Inc; F HOFFMANN-LA ROCHE AG |
Display screen or portion thereof with graphical user interface for interactive guidelines for multidisciplinary cancer treatment planning |
D936078, |
Oct 29 2019 |
Optum, Inc. |
Display screen or portion thereof with animated graphical user interface |
D940172, |
Oct 14 2019 |
ROCHE POLSKA SP ZO O; Roche Molecular Systems, Inc; F HOFFMANN-LA ROCHE AG; ASTEK POLSKA SP ZO O |
Display screen or portion thereof with graphical user interface for interactive guidelines for multidisciplinary cancer treatment planning |
///////////
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jan 15 2021 | | Roche Molecular Systems, Inc. | (assignment on the face of the patent) | | |
Mar 16 2021 | RAMANATHAN, RAMAN | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
Mar 16 2021 | PAREKH, KAUSHAL D | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
Mar 16 2021 | SHARMA, VISHAKHA | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
Mar 16 2021 | DORGE, ARCHANA P | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
Mar 16 2021 | CHAPAGAIN, DIWAKAR | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
Mar 17 2021 | BYRAPUNENI, SAMBASIVARAO | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
Mar 17 2021 | SCHLOSSMAN, DAVID M | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
Mar 22 2021 | BARBARD, CINDY K | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
Mar 26 2021 | JEU, CATHERINE M | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
May 10 2021 | KESAVAN, RENGARAJA PERUMAL | Roche Molecular Systems, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 056384 | 0044 |
pdf |
n/a
Date |
Maintenance Fee Events |
n/a
Date |
Maintenance Schedule |